[1]Vaught J.Biobanking comes of age:The transition to biospecimen science[J].Annu Rev Pharmacol Toxicol,2016(56):211-228.
[2]GAO HJ.Chinese biological sample bank.where is the road[J].Chinese Journal of Clinical Laboratory Management,2017,5(1):2-5.[郜恒骏.中国生物样本库:路在何方[J].中华临床实验室管理电子杂志,2017,5(1):2-5.]
[3]YU WQ.Basic medical data protection in the context of big data[J].Journal of Zhengzhou Institute of Aeronautical Industry Management (Social Science Edition),2016,35(2):103-105.[余文清.大数据背景下基本医疗数据保护探析[J].郑州航空工业管理学院学报(社会科学版),2016,35(2):103-105.]
[4]HAN Jiang,ZHOU Weimin,CHEN Han,et al.How to play the role of biological sample bank in clinical research[J].Journal of Translational Medicine,2018,7(06):346-349.[韩江,周为民,陈涵,等.如何发挥生物样本库在临床研究中的作用[J].转化医学杂志,2018,7(06):346-349.]
[5]Vora T,Thacker N.Impacts of a biobank:Bridging the gap in translational cancer medicine[J].Indian J Med Paediatr Oncol,2015,36(1):17-23.
[6]BAI LH,SHEN E,YANG J,et al.Research on ethical and legal issues of big data in biological sample banks[J].Chinese Medical Ethics,2017,30(10):1206-1200,1212.[白莉华,申锷,杨军,等.生物样本库大数据的伦理与法律问题研究[J].中国医学伦理学,2017,30(10):1206-1200,1212.]
[7]Feero WG,Wicklund CA,Veenstra D.Precision medicine,genome sequencing,and improved population health[J].JAMA,2018,319 (19):1979-1980.
[8]ZHAI Peijun,LI Junyan,HU Dongmei,et al.The biological sample library international recognition and standardized development and future[J].Chinese Journal of Clinical Laboratory Management Electronic,2017,5(01):6-8.[翟培军,李军燕,胡冬梅,等.生物样本库国际认可和标准化发展与前景[J].中华临床实验室管理电子杂志,2017,5(01):6-8.]
[9]Quinlan PR,Martin G,Jordan LB,et al.The informatics challenges facing biobanks:A perspective from a united kingdom biobanking network[J].Biopreserv Biobank,2015,13(5):363-370.
[10]Brown T,Kelly DD,Vercauteren SM,et al.How biobanks are assessing and measuring their financial sustainabilit[J].Biopreserv Biobank,2017,15(1):65-71.
[11]Sudmant PH,Mallick S,Nelson BJ,et al.Global diversity,population stratification,and selection of human copy-number variation[J].Science,2015,349(6253):aab3761.
[12]LENG Jing,WU Yaqin.Current situation and countermeasures of construction and application of biobank[J].Journal of Medical Informatics,2018,39(09):54-58.[冷静,吴亚琴.生物样本库建设与应用现状及其对策[J].医学信息学杂志,2018,39(09):54-58.]
[13]Kinkorová J.Biobanks in the era of personalized medicine:objectives,challenges,and Inno-vation[J].EPMA J,2016(7):4.
[14]SHI Xiaohong,GUO Jian.Development status of international biobank[J].Chinese Journal of Clinical Laboratory Management,2017,5(01):19-23.[史晓红,郭健.国际生物样本库的发展现状[J].中华临床实验室管理电子杂志,2017,5(01):19-23.]
[15]Holub P,Swertz M,Reihs R,et al.BBMRI-ERIC directory:515 biobanks with over 60 million biological samples[J].Biopreserv Biobank,2016,14(6):559-562.
[16]LIU Jiajian,XU Xiu,ZHONG Shengsheng,et al.Design and application of clinical resource database information management system[J].Chinese Digital Medicine,2017,12(12):73-74,80.[刘佳健,许修,仲生生,等.临床资源库信息管理系统的设计与应用[J].中国数字医学,2017,12(12):73-74,80.]
[17]MAN Qiuhong,YU Nong,YAN Fei,et al.Current situation and future development of China's biobank[J].China Pharmaceutical Biotechnology,2018,13(04):289-293.[满秋红,于农,闫飞,等.我国生物样本库建设现状与未来发展的思考[J].中国医药生物技术,2018,13(04):289-293.]
[18]YU YY.15 years review of the construction and development of gastrointestinal tumor biobank in China[J].Chinese Journal of Clinical Oncology,2016,43(1):6-10.[于颖彦.我国胃肠道肿瘤生物样本库建设与发展15年回顾[J].中国肿瘤临床,2016,43(1):6-10.]
[19]LI Qian,JIN Liping,ZHOU Xuexun.Current situation of operation planning of biological sample bank in China[J].Union Medical Journal,2018,9(03):271-276.[李倩,金莉萍,周学迅.我国生物样本库运营规划现状[J].协和医学杂志,2018,9(03):271-276.]
[20]ZHANG Yuanyuan,WANG Liang,CHENG Longmei,et al.Application and challenges of information-based management of biological samples[J].Chinese Journal of Clinical Pharmacology,2018,34(14):1710-1713.[张媛媛,王亮,程龙妹,等.生物样本信息化管理的应用与挑战[J].中国临床药理学杂志,2018,34(14):1710-1713.]
[21]WANG WY.The feasibility of applying clinical electronic information in clinical research[J].Chinese Journal of Clinical Laboratory Management,2015,3(4):193-197.[王伟业.浅谈临床电子化信息应用于临床研究的可行性[J].中华临床实验室管理电子杂志,2015,3(4):193-197.]
[22]SHAO YK,ZENG L,ZHENG J.Analysis and discussion on current situation of safety management in biological laboratory[J].Strategy Innovation Dev Sci Technol,2018,2(4):10-14.[邵玉昆,曾莉,郑健.生物类实验室安全管理现状分析与探讨[J].科技创新发展战略研究,2018,2(04):10-14.]
[23]JIANG Hui,LI Hongying,LI Zhenliang,et al.Reflections on the focus of China's biological sample database construction and achievement transformation[J].Medicine and Philosophy,2017,38 (2A):31-34.[蒋辉,李红英,李振良,等.我国生物样本库建设与成果转化焦点问题思考[J].医学与哲学,2017,38 (2A):31-34.]
[24]ZHAO Liyan.Informed consent process and informed consent exemption for biomedical research[J].Medicine and Philosophy,2017,38(3A):27-29.[赵励彦.生物医学研究的知情同意过程及知情同意豁免[J].医学与哲学,2017,38(3A):27-29.]
[25]MAN Qiuhong,CHEN Yunzhao,WANG Weiye.The construction concept of biological sample bank reconstruction to promote the coordinated application and development of clinical research resources[J].Chinese Journal of Peking Union Medical College,2019,05(29):1-9.[满秋红,陈云昭,王伟业.重构生物样本库建设理念促进临床研究资源协同应用和发展[J].协和医学杂志,2019,05(29):1-9.]
[26]LIU Xiaohai,FENG Ming,LIU Chuang,et al.Construction and application of tumor biobank in research hospitals[J].Big Doctor,2018,3(08):177-178.[刘小海,冯铭,刘闯,等.研究型医院肿瘤生物样本库的构建和应用[J].大医生,2018,3(08):177-178.]
[27]XU Linyu.On the general data protection regulations of the European Union[J].World Science,2018,03(11):38-40.[许林玉.欧盟《通用数据保护条例》探微[J].世界科学,2018,03(11):38-40.]
[28]GAO HJ.The progression of standardization for the biobank in China[J].Chin Med Biotechnol,2015,10(6):481-483.[郜恒骏.中国生物样本库向标准化迈进[J].中国医药生物技术,2015,10(6):481-483.]
[29]LIU YH,HU Y,ZHANG QQ,et al.Standardization of project management process of biological sample database[J].Chinese Medicinal Biotechnology,2017,12(4):372-374.[刘艳红,胡月,张倩倩,等.生物样本库项目管理流程的规范化[J].中国医药生物技术,2017,12(4):372-374.]
[30]ZHAO Cong,DAI Tao,WANG Nan,et al.A study on the sharing of biological sample database in China based on content analysis[J].Chinese Journal of Medical Sciences,2017,26(2):38-41.[赵聪,代涛,汪楠,等.基于内容分析法的我国生物样本库共享问题研究[J].中华医学图书情报杂志,2017,26(2):38-41.]
[31]DU LL.Standardization construction of biological sample database[J].Journal of Translational Medicine,2016,5(6):324-326.[杜莉利.生物样本库的标准化建设[J].转化医学杂志,2016,5(6):324-326.]
[32]XU Yan,FAN Ping,HU Xun.Key problems and solutions in the construction of biological sample bank[J].West China Medicine,2018,33(06):651-654.[徐艳,樊萍,胡迅.生物样本库建设的关键问题及解决策略[J].华西医学,2018,33(06):651-654.]
[33]WANG Zhao,ZHAO Yueran,CAO Yongzhi.Whole process management of large biobank based on Internet of things[J].Journal of Translational Medicine,2008,7(06):350-353.[王钊,赵跃然,曹永芝.基于物联网的大型生物样本库全流程管理[J].转化医学杂志,2018,7(06):350-353.]
[34]SHAN Fang,MAO Xinzhi.Ethical challenges and coping strategies of informed consent in biobanks[J].Natural Dialectics Communications,2019,41(03):110-115.[单芳,毛新志.生物样本库研究中知情同意问题的伦理挑战和应对策略[J].自然辩证法通讯,2019,41(03):110-115.]
[35]LI Na,MA Lin,ZHAN Qimin.Towards precision medicine[J].Chinese Journal of Tumor Biotherapy,2019,26(01):3-6.[李娜,马麟,詹启敏.迈向精准医学[J].中国肿瘤生物治疗杂志,2019,26(01):3-6.]
[36]HE Rui,DONG Yan,LIU Jing,et al.Typical human genetic resource management model and its enlightenment to China[J].Chinese Medical Biotechnology,2008,13(06):566-568.[何蕊,董妍,刘静,等.典型人类遗传资源管理模式及对我国的启示[J].中国医药生物技术,2018,13(06):566-568.]